| Title | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Endep (Amitriptyline Hydrochloride) Oral Concentrate, 40 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| ToC Doc | Endep (Amitriptyline Hydrochloride) Oral Concentrate, 40 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Docket Number | 2022-20195 |
| Type | Notice |
| Subject | Drug Products not Withdrawn from Sale for Reasons of Safety or Effectiveness: Endep (Amitriptyline Hydrochloride) Oral Concentrate, 40 Milligrams/Milliliter, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Publication Date | 2022-09-19 |
| Last Updated Date | 2022-09-16 08:15:10 -0400 |
| Last Public Inspection | 2022-09-16 |
| Filed At | 2022-09-16T08:45:00.000-04:00 |
| 2022-20195_PI.pdf (99794 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 3 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...